Posaconazole

Chemical formula: C₃₇H₄₂F₂N₈O₄  Molecular mass: 700.777 g/mol  PubChem compound: 468595

Therapeutic indications

Posaconazole is indicated for:

Refractory invasive fungal infections (IFI)

Population group: only adults (18 years old or older)

Deep mycosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Oropharyngeal candidiasis

Population group: only adults (18 years old or older)

at least one of
Candidiasis of mouth
Pharyngeal candidiasis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prophylaxis of invasive fungal infections

Population group: only adults (18 years old or older)

Preventive procedure and additionally Deep mycosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Posaconazole is contraindicated in the following cases:

Ergot alkaloids

at least one of
Ergot alkaloids
Ergot alkaloids
Ergot alkaloids

Substrates known to prolong the QT-interval that are subject to metabolism by CYP3A4

Drugs prolonging QT interval and additionally CYP3A4 substrates

HMG-CoA reductase inhibitors metabolised through CYP3A4

HMG CoA reductase inhibitors and additionally CYP3A4 substrates

Terfenadine, astemizole, cisapride, pimozide, halofantrine, quinidine

at least one of
Terfenadine
Astemizole
Cisapride
Pimozide
Halofantrine
Quinidine

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.